Khuloud Al-Jamal, is a Global STEM Professor, the Director of the Jockey Club STEM Lab of Advanced Therapies for Nanomedicines and The Head of Pharmacology & Pharmacy at LKS Faculty of Medicine, The University of Hong Kong. She holds a concurrent appointment as a Chair of Drug Delivery & Nanomedicine, Institute of Pharmaceutical Science, King’s College London. She served as The Head of Medicines Development at the Institute of Pharmaceutical Science, King’s College London (2020-2024) where she also developed herself as an independent researcher since her appointment as an Assistant Professor in 2011 to becoming a Full Professor in 2016. Professor Al-Jamal completed her PhD at the Centre for Drug Delivery Research and postdoctoral training at the Nanomedicine Lab, The School of Pharmacy, University of London (2000-2010). She undertook her pre-registration pharmacy training at University College London Hospitals. Her research focusses on developing nanomedicines and advanced therapies to improve treatment of neurological diseases and cancer.  She published over 170 articles which attracted ~11,500 citations (by 2024). She supervised over 150 researchers and attracted over $HKD 200M of funding.

She is a recipient of the Royal Pharmaceutical Society of Great Britain Science Medal, becoming the third female to receive this award in a 43-year-history, Maplethorpe Fellowship for the promotion of pharmaceutical education and excellence in research (University of London), BBSRC New Investigator Award, the Controlled Release Society Nanomedicine and Nanoscale Delivery Young Investigator Award. She is a three-time winner of the Wellcome Trust Science Image Awards.

She is an editorial board member for several journals such as Journal of Controlled Release, Biomaterials Science, Scientific Reports, MedBioMed and Journal of Drug Targeting. She is a Fellow of Royal Society of Chemistry and The Royal Pharmaceutical Society of Great Britain.